Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Future Medicinal Chemistry|April 19, 2019
Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trendsEdoardo Fabini, Elisabetta Manoni, Claudia Ferroni, et al.Molecular Informatics|July 29, 2016
Predicting the Thermal Stability of Nitroaromatic Compounds Using Chemoinformatic ToolsGuillaume Fayet, Alberto Del Rio, Patricia Rotureau, et al.Toxicologic Pathology|December 10, 2016
Translational Safety GeneticsPriyasma Bhoumik, Alberto Del Rio-Espinola, Florian Hahne, et al.Current Pharmaceutical Design|September 29, 2012
Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesFederico Andreoli, Arménio Jorge Moura Barbosa, Marco Daniele Parenti, et al.Current Pharmaceutical Design|September 29, 2012
ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6Nadia Dani, Armenio Jorge Moura Barbosa, Alberto Del Rio, et al.Chirality|July 9, 2004
Theoretical reassessment of Whelk-O1 as an enantioselective receptor for 1-(4-halogeno-phenyl)-1-ethylamine derivativesAlberto Del Rio, Joseph M Hayes, Matthias Stein, et al.Journal of Chromatography. A|June 25, 2004
Chiral liquid chromatography contribution to the determination of the absolute configuration of enantiomersChristian Roussel, Alberto Del Rio, Johanna Pierrot-Sanders, et al.Molecular Biosystems|August 10, 2010
CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposesAlberto Del Rio, Arménio Jorge Moura Barbosa, Fabiana Caporuscio, et al.Plos One|December 11, 2012
Chemoinformatic analysis of GRAS (Generally Recognized as Safe) flavor chemicals and natural productsJosé L Medina-Franco, Karina Martínez-Mayorga, Terry L Peppard, et al.Plos One|July 11, 2014
Inhibition of human dyskerin as a new approach to target ribosome biogenesisLaura Rocchi, Arménio J M Barbosa, Carmine Onofrillo, et al.Pageof 9